|Chemical and physical data|
|Molar mass||480.856 g/mol g·mol−1|
|3D model (JSmol)|
EGIS-12,233 is a drug with applications in scientific research, acting as a potent and selective antagonist for both the 5-HT6 and 5-HT7 serotonin receptor subtypes, with good selectivity over other receptors. It has been shown to increase dopamine release in cochlear tissue, suggesting a role for the 5-HT6 and 5-HT7 receptors in regulation of the hearing system.
(no additional rings)
(piperazine attached via side chain)
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|